CardioKinetix Inc. Announces First Heart Failure Patients Treated in Asia with Minimally Invasive Structural Heart Device

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MENLO PARK, Calif.--(BUSINESS WIRE)--CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced a new first with four patients successfully treated this week with the novel catheter-based Parachute® Ventricular Partitioning Device in Kuala Lumpur, Malaysia.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC